IBDEI2TO ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45017,1,3,0)
 ;;=3^Postprocedure Hemorrhage of Skin/SQ Tissue After Derm Procedure
 ;;^UTILITY(U,$J,358.3,45017,1,4,0)
 ;;=4^L76.21
 ;;^UTILITY(U,$J,358.3,45017,2)
 ;;=^5009306
 ;;^UTILITY(U,$J,358.3,45018,0)
 ;;=L76.22^^170^2243^26
 ;;^UTILITY(U,$J,358.3,45018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45018,1,3,0)
 ;;=3^Postprocedure Hemorrhage of Skin/SQ Tissue After Oth Procedure
 ;;^UTILITY(U,$J,358.3,45018,1,4,0)
 ;;=4^L76.22
 ;;^UTILITY(U,$J,358.3,45018,2)
 ;;=^5009307
 ;;^UTILITY(U,$J,358.3,45019,0)
 ;;=L41.9^^170^2243^3
 ;;^UTILITY(U,$J,358.3,45019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45019,1,3,0)
 ;;=3^Parapsoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,45019,1,4,0)
 ;;=4^L41.9
 ;;^UTILITY(U,$J,358.3,45019,2)
 ;;=^5009177
 ;;^UTILITY(U,$J,358.3,45020,0)
 ;;=L70.5^^170^2243^14
 ;;^UTILITY(U,$J,358.3,45020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45020,1,3,0)
 ;;=3^Picker's Acne
 ;;^UTILITY(U,$J,358.3,45020,1,4,0)
 ;;=4^L70.5
 ;;^UTILITY(U,$J,358.3,45020,2)
 ;;=^5009272
 ;;^UTILITY(U,$J,358.3,45021,0)
 ;;=L81.9^^170^2243^15
 ;;^UTILITY(U,$J,358.3,45021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45021,1,3,0)
 ;;=3^Pigmentation Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,45021,1,4,0)
 ;;=4^L81.9
 ;;^UTILITY(U,$J,358.3,45021,2)
 ;;=^5009319
 ;;^UTILITY(U,$J,358.3,45022,0)
 ;;=L66.3^^170^2243^7
 ;;^UTILITY(U,$J,358.3,45022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45022,1,3,0)
 ;;=3^Perifolliculitis Capitis Abscedens
 ;;^UTILITY(U,$J,358.3,45022,1,4,0)
 ;;=4^L66.3
 ;;^UTILITY(U,$J,358.3,45022,2)
 ;;=^5009255
 ;;^UTILITY(U,$J,358.3,45023,0)
 ;;=R23.3^^170^2243^13
 ;;^UTILITY(U,$J,358.3,45023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45023,1,3,0)
 ;;=3^Petechiae
 ;;^UTILITY(U,$J,358.3,45023,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,45023,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,45024,0)
 ;;=D69.3^^170^2243^46
 ;;^UTILITY(U,$J,358.3,45024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45024,1,3,0)
 ;;=3^Purpura Immune Hemorrhagic/Idopathic Thrombocytopenic
 ;;^UTILITY(U,$J,358.3,45024,1,4,0)
 ;;=4^D69.3
 ;;^UTILITY(U,$J,358.3,45024,2)
 ;;=^332746
 ;;^UTILITY(U,$J,358.3,45025,0)
 ;;=D69.2^^170^2243^47
 ;;^UTILITY(U,$J,358.3,45025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45025,1,3,0)
 ;;=3^Purpura Simplex
 ;;^UTILITY(U,$J,358.3,45025,1,4,0)
 ;;=4^D69.2
 ;;^UTILITY(U,$J,358.3,45025,2)
 ;;=^5002366
 ;;^UTILITY(U,$J,358.3,45026,0)
 ;;=L76.31^^170^2243^23
 ;;^UTILITY(U,$J,358.3,45026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45026,1,3,0)
 ;;=3^Postprocedure Hematoma of Skin/SQ After Derm Procedure
 ;;^UTILITY(U,$J,358.3,45026,1,4,0)
 ;;=4^L76.31
 ;;^UTILITY(U,$J,358.3,45026,2)
 ;;=^5138774
 ;;^UTILITY(U,$J,358.3,45027,0)
 ;;=L76.32^^170^2243^24
 ;;^UTILITY(U,$J,358.3,45027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45027,1,3,0)
 ;;=3^Postprocedure Hematoma of Skin/SQ After Oth Procedure
 ;;^UTILITY(U,$J,358.3,45027,1,4,0)
 ;;=4^L76.32
 ;;^UTILITY(U,$J,358.3,45027,2)
 ;;=^5138775
 ;;^UTILITY(U,$J,358.3,45028,0)
 ;;=R73.03^^170^2243^27
 ;;^UTILITY(U,$J,358.3,45028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45028,1,3,0)
 ;;=3^Pre-Diabetes
 ;;^UTILITY(U,$J,358.3,45028,1,4,0)
 ;;=4^R73.03
 ;;^UTILITY(U,$J,358.3,45028,2)
 ;;=^8295662
 ;;^UTILITY(U,$J,358.3,45029,0)
 ;;=L71.9^^170^2244^7
 ;;^UTILITY(U,$J,358.3,45029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45029,1,3,0)
 ;;=3^Rosacea,Unspec
